Home Healthcare Medical Devices Smart Stethoscope Market

Smart Stethoscope Market Size, Share & Trends Analysis Report By Application (Cardiovascular, Neonatal, Pediatric, Fetal, Teaching, Others), By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:

Smart Stethoscope Market Size

The global smart stethoscope market size was valued at USD 64.8 million in 2025 and is projected to grow from USD 69.32 million in 2026 to USD 118.93 million by 2034, registering a CAGR of 6.98% during the forecast period from 2026 to 2034. North America dominated the smart stethoscope market with a market share of 38.6% in 2025.

Traditional stethoscopes have been replaced with smart or electronic stethoscopes. Intelligent stethoscopes convert sound waves into electronic impulses and amplify them to facilitate clear hearing. It is user-friendly and cost-effective equipment that allows physicians to receive dependable clinical results. Smart stethoscopes are emerging as a new treatment system for home health care. These stethoscopes aid in the diagnosis of cardiovascular and pulmonary illnesses. Traditional stethoscopes had numerous drawbacks, including low sound quality. This disadvantage was most noticeable in obese people and those with thick chest walls. Other disadvantages were the need for qualified personnel to explore and understand the results, expensive expenses, and restricted distribution to advanced healthcare facilities. On the other hand, smart stethoscopes are very inexpensive, easy to use, and generally available for physicians and paramedical workers. This is a crucial element driving the global market growth for smart stethoscopes.

The smart stethoscope is a user-friendly, cost-effective technology that helps clinicians acquire accurate results. These stethoscopes aid in the identification of respiratory illnesses and disorders based on heart rate. Until recently, the classic stethoscope has played an essential role in the cardiology department. The downsides of the medical equipment include low sound quality, which is especially obvious in obese people and those with a thick chest wall. Consequently, there is a burgeoning need for improved stethoscopes to replace the traditional medical version, resulting in market expansion. High frequency of cardiovascular illnesses and improved diagnostics are further market drivers.

Smart Stethoscope Market Size

Download a Free Sample To learn more about this report.

Application Insights

The cardiology category dominated the market for smart stethoscopes and held the most significant revenue share of 28.8 % in 2021 and is predicted to exhibit a special growth rate over the forecast period. The cardiology stethoscope is intended for use by cardiologists and is recognised for its high-quality acoustics. It is used to listen to noises created by many sections of the cardiovascular system, such as heartbeat, valve movement, clicks, murmurs, and other activities. These stethoscopes, like standard stethoscopes, may be used for various reasons. In the end, compared to generic stethoscopes, the cardiology stethoscope is meant to offer more outstanding sound quality. Most cardiology stethoscopes contain a pressure-tunable diaphragm that helps to discriminate between high and low-frequency sounds. Moreover, increasing heart-related illnesses also enhance the demand for cardiovascular stethoscopes globally.

Smart Stethoscope Market Size By Segments

Request Customizationto receive a tailored report.

End-Use Insights

In 2021, the hospital element dominated the market for smart stethoscopes, commanding a revenue share of 61.9%. During the projection period, it is predicted that the segment will increase at a rapid rate. The critical factor driving category expansion is the increasing prevalence of cardiovascular and respiratory diseases. In addition, an increasing number of older patients are admitted to hospitals for the initial diagnosis of chronic health conditions. For instance, according to the CDC, adults over 65 are more likely to suffer from significant health conditions such as heart disease, the common cold and cough, asthma, chronic obstructive pulmonary disease, diabetes, and other problems. In addition, smart stethoscopes enable medical practitioners to record patients' lung and heart sounds and incorporate them into the hospital's electronic health record systems. Thus, the expansion of this category is driven by the rising demand for technologically advanced stethoscopes. Over the projected period, the Ambulatory Surgical Centers (ASCs) segment is anticipated to develop significantly. 36.0% of outpatient surgical procedures were performed in the United States, according to information compiled by Becker's Healthcare. An upgrade in the number of surgical procedures conducted contributes to segmental expansion. In addition, according to Definitive Healthcare's platform on surgery centres, there are approximately 9,280 active ASCs in the U.S. Increased patient desire for outpatient treatments may increase the utilisation of intelligent stethoscopes in ambulatory surgical centres, hence expanding market share.

Smart Stethoscope Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America dominated the smart stethoscopes market in 2021, accounting for 33.3 % of the total revenue. It is anticipated that the segment will experience a phenomenal growth rate of 6.2% over the projection period.

The key factors driving industry growth are the escalation in chronic diseases, such as cardiovascular and respiratory conditions, as a result of an unhealthy lifestyle and the presence of well-developed healthcare infrastructure. The prevalence of cardiovascular disorders is rising in North America, which is expected to increase the need for stethoscopes in the region. Moreover, according to CMS data, U.S. health care expenditures increased by 4.6% in 2021, reaching USD 3.8 trillion. According to the Canadian Institute for Health Information, Canada's total healthcare expenditures in 2021 amounted to USD 264 billion, or 11.6% of the country's gross domestic product. Thus, rising healthcare expenditures are contributing to the North American smart stethoscope market's growth.

North America Smart Stethoscope Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Over the forecast period, the Asia-Pacific market for smart stethoscopes is anticipated to exhibit a lucrative CAGR of 7.5%. The region's large patient population is anticipated to generate significant growth opportunities for the business. In addition, rising R&D expenditures by leading market players due to their low-cost structures are high-impact market drivers in Asia-Pacific. Increasing understanding of chronic disease treatment and developments in the clinical development framework of developing countries are projected to propel market growth in this sector.

List of Key and Emerging Players in Smart Stethoscope Market

3M
Thinklabs
HD Medical Inc.
Eko Devices Inc.
eKuore
M3DICINE Pty Ltd.
Sonavi Labs
Steth IO
Eko Devices Inc.
FarmaSino Pharmaceuticals Jiangsu Co. Ltd.
Contec Medical Systems Co. Ltd.
Rudolf Riester GmbH
American Diagnostic Corporation
Cardionics
HEINE Optotechnik GmbH & Co. KG
Medical Catalog Enterprises Inc.
ERKA
Kallmeyer Medizintechnik GmbH & Co. KG
Prestige Medical
SUZUKEN CO.
LTD.
Timesco Healthcare Ltd.
Ultrascope.
Sklar Surgical Instruments.
Qufu Longer Care Meditech Limited
Qinhuangdao Exanovo Group
Think Labs Medical LLC
Sensi Cardiac.

Key Industry Developments

March 2026
TytoCare received U.S. FDA clearance for an updated Tyto Stethoscope incorporating AI-enabled heart rate calculation from recorded heart sounds, strengthening its remote examination and digital auscultation capabilities.
February 2026
Wayne General Hospital partnered with Eko Health to deploy the SENSORA AI-assisted cardiac detection platform across emergency and primary care departments, integrating smart digital stethoscopes and FDA-cleared AI algorithms into frontline clinical workflows.
December 2025
eMurmur received U.S. FDA clearance for eMurmur Heart AI, an interoperable AI-based murmur detection solution designed to analyze recordings from supported digital stethoscopes and integrate with third-party software platforms.
September 2025
Eko Health received U.S. FDA clearance for its EFAST cardiac foundation model, enabling AI-assisted detection of structural heart murmurs and atrial fibrillation through its digital stethoscope platform.

Report Scope

Segmentation

By Application 6
  • Cardiovascular
  • Neonatal
  • Pediatric
  • Fetal
  • Teaching
  • Others
By End-Use 3
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage 3M · Thinklabs · HD Medical Inc. · Eko Devices Inc. · eKuore
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The smart stethoscope market size is valued at USD 69.32 Million in 2026 and is projected to reach USD 118.93 Million by 2034, at a CAGR of 6.98% during the forecast period 2026-2034.
North America dominated the market with a share of 38.6% in 2025.
The leading players in this market are 3M, Thinklabs, HD Medical Inc., Eko Devices Inc., eKuore.
The smart stethoscope market is projected to grow at a CAGR of 6.98% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now